AbbVie

Recent News About AbbVie

Botox selects women entrepreneurs for confidence project grants

By Business Daily | Jul 22, 2025

Allergan Aesthetics, a company under AbbVie, has announced the selection of entrepreneurs for The Confidence Project: Empowering Women Entrepreneurs.

AbbVie announces global licensing deal with IGI for new cancer therapy

By Business Daily | Jul 10, 2025

AbbVie and Ichnos Glenmark Innovation (IGI) have announced an exclusive licensing agreement for ISB 2001, a trispecific antibody currently in Phase 1 clinical trials for relapsed/refractory multiple myeloma.

AbbVie announces date for second-quarter 2025 earnings release

By Business Daily | Jun 30, 2025

AbbVie has announced plans to release its second-quarter 2025 financial results on July 31, 2025.

AbbVie acquires Capstan Therapeutics for $2.1 billion

By Business Daily | Jun 30, 2025

AbbVie has announced its acquisition of Capstan Therapeutics, a clinical-stage biotechnology company focused on in vivo cell engineering through RNA delivery.

FDA reviews Allergan's application for expanding SKINVIVE indication

By Business Daily | Jun 30, 2025

The U.S. Food and Drug Administration (FDA) has accepted for review a supplemental premarket approval application from Allergan Aesthetics, an AbbVie company, for the product SKINVIVE by JUVÉDERM.

AbbVie announces quarterly dividend payment set for August 2025

By Business Daily | Jun 20, 2025

The board of directors at AbbVie Inc. has announced a quarterly cash dividend of $1.64 per share.

AbbVie's Phase 3 study shows promising results for migraine prevention drug

By Business Daily | Jun 18, 2025

AbbVie has announced results from its Phase 3 TEMPLE study, which evaluated the tolerability, safety, and efficacy of atogepant compared to topiramate for migraine prevention in adults.

AbbVie to join Goldman Sachs healthcare conference with webcast available

By Business Daily | Jun 3, 2025

AbbVie is set to participate in the Goldman Sachs 46th Annual Global Healthcare Conference.

AbbVie opens submissions for second annual Migraine Career Catalyst Award

By Business Daily | Jun 3, 2025

The AbbVie Migraine Career Catalyst Award contest is now open for entries, offering financial support to individuals living with migraine who wish to pursue their professional and career development goals.

AbbVie partners with Chicago Cubs for 'Striking Out Cancer' campaign

By Business Daily | May 30, 2025

AbbVie has announced a multi-year partnership with the Chicago Cubs, launching a campaign titled "Striking Out Cancer."

AbbVie presents new data on cancer treatments at ASCO 2025

By Business Daily | May 27, 2025

AbbVie is set to present new data from its oncology portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 30 to June 3, 2025.

FDA approves new treatment for advanced non-small cell lung cancer

By Business Daily | May 14, 2025

AbbVie has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for EMRELIS (telisotuzumab vedotin-tllv).

AbbVie partners with ADARx Pharmaceuticals on next-generation siRNA therapies

By Business Daily | May 14, 2025

AbbVie and ADARx Pharmaceuticals have entered into a collaboration and license option agreement to develop small interfering RNA (siRNA) therapeutics.

AbbVie to join Bank of America healthcare conference with fireside chat

By Business Daily | May 6, 2025

AbbVie announced its participation in the Bank of America Securities Healthcare Conference, scheduled for May 14, 2025.

BOTOX plans to empower 50,000 women entrepreneurs by 2030 through The Confidence Project

By Business Daily | May 1, 2025

Allergan Aesthetics, a division of AbbVie, has reaffirmed its commitment to supporting women entrepreneurs through its BOTOX Cosmetic initiative named "The Confidence Project: Empowering Women Entrepreneurs."

Allergan Aesthetics unveils new faculty for inaugural AMI training centers

By Business Daily | Apr 30, 2025

Allergan Aesthetics, a company under AbbVie, has announced the launch of the inaugural Allergan Medical Institute (AMI) Training Centers Faculty.

AbbVie seeks FDA approval for TrenibotE to treat glabellar lines

By Business Daily | Apr 24, 2025

AbbVie has taken a significant step in the aesthetics field by submitting a Biologics License Application to the U.S. Food and Drug Administration for its product trenibotulinumtoxinE (TrenibotE).

AbbVie to release first-quarter 2025 earnings on April 25

By Business Daily | Mar 31, 2025

AbbVie is set to release its first-quarter financial outcomes for 2025 on April 25, prior to the market opening.

AbbVie to present oncology advances at AACR Annual Meeting 2025

By Business Daily | Mar 26, 2025

AbbVie has announced that it will present new data from its early oncology research at the American Association of Cancer Research (AACR) Annual Meeting, scheduled for April 25-30, 2025.

Allergan showcases innovation at AMWC 2025 with new AA Signature program

By Business Daily | Mar 24, 2025

Allergan Aesthetics, a subsidiary of AbbVie, is showcasing its latest innovations at the Anti-Aging and Aesthetics Medicine World Congress (AMWC) in Monaco from March 27 to March 29, 2025.

Trending

Recent News About AbbVie

Nurse practitioner of Del Rey MD: ‘Sinusitis is basically inflammatory process of the passages inside of your nose’

Binance Founder: Giggle Academy is 'focused in poor areas no one wants to go build schools today'

Otolaryngologist on sinus infections and allergies: ‘They're two separate diagnoses, but they both work together to cause issues'

National Breathe Free earns Great Place to Work certification for 2025-2026

Amazon says 425,000 U.S. employees gained new skills through Upskilling 2025